How Pfizer is supporting SDG #3: Good health and well-being

Caroline Roan: We were proud to sign on to the UN Sustainable Development Goals.

For us goal number three is our north star: "Good health and wellbeing." Every day our scientists are working to discover, develop and bring to market medicines and vaccines that help people live longer and healthier lives. And for us goal number three allowed us to have a dialogue and an engagement with the United Nations and with governments globally to ensure that we're partnering with them to provide access to quality healthcare.

When we think about access to medicines we think about a comprehensive strategy that includes both donation and philanthropic support as well as creative commercial strategies designed to drive access to the most vulnerable and underserved populations globally.

So for Pfizer we have a number of initiatives that we're very proud of. One which I like to say is our oldie but goodie was launched in 1998. The International Trachoma Initiative was launched to address a blinding disease called trachoma. At the time it was launched, we had a product that treated active infection that causes this disease. And if the infection goes untreated over time people do go blind. And what we discovered was that our medicine could treat this infection, but our medicine was not sufficient: Alone that medicine would not do the work that needed to be done at a public health level.

For our work to address a blinding disease called trachoma we've used a public health strategy called SAFE. SAFE stands for surgery – S, for advanced cases of the disease. A – the distribution of the antibiotic that Pfizer makes to treat the active infection. F which is face washing and E which is environmental development. Together that comprehensive initiative working now with more than a hundred partners has achieved elimination of this disease in six countries. That's profound. And it's one of our greatest accomplishments as a company. It did not happen overnight. It has taken more than two decades to achieve that progress, but we have our eyes on the prize which is full elimination of this disease by the year 2020.

Another example where Pfizer is working to meet the evolving global health needs is in the area of oncology. We have chemotherapy agents that are very important for patients globally. And we worked with our partners, the American Cancer Society, the Clinton Health Access Initiative, and CIPLA to make 11 prioritized chemotherapy agents available in East Africa where there is a disproportionate burden of cancer. We're really proud of that initiative because we're taking some of our very important core essential medicines and making them available to reach more patients in areas of the world that several years ago did not have this need.

So the business case for corporate responsibility has been debated for years and there are different perspectives on this. I think for Pfizer and for the pharmaceutical companies we can't deliver our business unless we deliver for society.Keeping that patient that we serve front and center to how we make the decisions that the company takes every single day.

When we discover, develop and bring to market medicines and vaccines that help people live longer and healthier lives our communities are healthier, society is healthier, and we deliver both for our business and our shareholders, but also for society.

  • The United Nations Sustainable Development Goals (SDG) are a set of 17 directives to be completed by a 2030 deadline, with the aim of significantly improving quality of life for all people on Earth.
  • Pfizer's commitment to the UN's SDG #3, Good Health and Well-being, is exemplified by its mission to improve global health through a combination of local and global programs catalyzed by innovative health leaders.
  • In 1998, Pfizer embarked on a 22-year mission to eradicate trachoma by 2020.Trachoma is an infectious eye disease that can cause irreversible blindness or vision impairment. So far, it has been eradicated in six countries.
  • Pfizer is a committed partner in improving global health, helping to provide a number of critical cancer medications to six African countries where an estimated 44 percent of all cancer cases in sub-Saharan Africa occur each year

‘Designer baby’ book trilogy explores the moral dilemmas humans may soon create

How would the ability to genetically customize children change society? Sci-fi author Eugene Clark explores the future on our horizon in Volume I of the "Genetic Pressure" series.

Surprising Science
  • A new sci-fi book series called "Genetic Pressure" explores the scientific and moral implications of a world with a burgeoning designer baby industry.
  • It's currently illegal to implant genetically edited human embryos in most nations, but designer babies may someday become widespread.
  • While gene-editing technology could help humans eliminate genetic diseases, some in the scientific community fear it may also usher in a new era of eugenics.
Keep reading Show less

Massive 'Darth Vader' isopod found lurking in the Indian Ocean

The father of all giant sea bugs was recently discovered off the coast of Java.

A close up of Bathynomus raksasa

SJADE 2018
Surprising Science
  • A new species of isopod with a resemblance to a certain Sith lord was just discovered.
  • It is the first known giant isopod from the Indian Ocean.
  • The finding extends the list of giant isopods even further.
Keep reading Show less

These are the world’s greatest threats in 2021

We look back at a year ravaged by a global pandemic, economic downturn, political turmoil and the ever-worsening climate crisis.

Luis Ascui/Getty Images
Politics & Current Affairs

Billions are at risk of missing out on the digital leap forward, as growing disparities challenge the social fabric.

Keep reading Show less

Columbia study finds new way to extract energy from black holes

A new study explains how a chaotic region just outside a black hole's event horizon might provide a virtually endless supply of energy.

Credit: NASA's Goddard Space Flight Center
Surprising Science
  • In 1969, the physicist Roger Penrose first proposed a way in which it might be possible to extract energy from a black hole.
  • A new study builds upon similar ideas to describe how chaotic magnetic activity in the ergosphere of a black hole may produce vast amounts of energy, which could potentially be harvested.
  • The findings suggest that, in the very distant future, it may be possible for a civilization to survive by harnessing the energy of a black hole rather than a star.
Keep reading Show less
Mind & Brain

A psychiatric diagnosis can be more than an unkind ‘label’

A popular and longstanding wave of thought in psychology and psychotherapy is that diagnosis is not relevant for practitioners in those fields.

Scroll down to load more…
Quantcast